March 2014 Issue of MMM
MARCH 2014 issue
At any given time, 25-40% of your staff don't know how to do their jobs
Click the above link to access the complete Digital Edition of the March 2014 issue, with all text, charts and pictures.
Five areas in which innovative uses of data and analytics promise to improve outcomes along the healthcare continuum. Marc Iskowitz reports
The downward spiral for journals continues. Is anyone surprised? Larry Dobrow on how the fundamental shift to digital continued to affect professional media last year, ...
As orphan and specialty drugs account for a larger part of total spend, insurers say a barrage of tactics are needed to manage costs. Sarah ...
Hundreds of industry execs assembled in New York to pay tribute to the careers of the 2014 MAHF honorees
You have less than eight weeks left to enter the MM&M Awards. No problem. Give yourself the best chance of success by following our checklist ...
Carrie Bourdow, Vice president, marketing, Cubist Pharmaceuticals
The launch front in this category is relatively calm—for now. A movement is brewing to unseat the top diabetes drug, a long-acting insulin, as faster-acting ...
A new industry has emerged to provide analytics and predictive tools that support optimized care
We are reaching an exciting new time in medicine when genetics will play a major role in predicting and treating disease
Last year's merger of two big ad networks prompted indie shops to step up recruiting, and get creative. Blanketed media buys, organ-themed T-shirts and ice ...
The new network, PD One, will allow reps to connect with HCPs through PDI's Medical Bag.
Ashfield unites its businesses under the Ashfield Commercial & Medical Services banner
News on Johnson & Johnson, Novartis and Merck
Med Ed Report
A report indicates pharma companies do not agree on what research needs to be reported.
Alexion is focusing on medical education ahead of an anticipated approval of asfotase alfa for patients with hypophosphatasia, or HPP
News on the CBI Pharmaceutical Compliance Congress, Eli Lilly and New York TImes
Within four days, drug resource MPR hit two milestones of note: reaching one million monthly views as of February 3 and moving from a soft ...
Wolters Kluwer Health has renamed Lippincott's Nursing Advisor the Lippincott Advisor
News on PLOS, PMLiVE and Elsevier
A young company is hoping its analytics platform can help doctors and pharma figure out who's going to stop taking their medication, and get them ...
A six-month pilot program at the University of Chicago improved glycemic control and engaged patients and HCPs through one key device: a mobile phone.
News on IBM, Google, Glooko and Welltok
J&J's campaign picks up where the FDA left off when it alerted physicians to concerns about prescribing acetaminophen-containing drugs but deferred action relative to OTC ...
Latuda, a new bipolar anti-depression brand from Sunovion, has joined the DTC fray with an integrated campaign targeted at women betweeen 25 and 49.
Consumers are paying attention to OTC side effects, a study by research firm Mintel shows
Suppliers are touting a deeper level of analysis, in some cases bypassing the market-research function and reaching the highest levels of their pharma clients.
National Pharmaceutical Council (NPC) said Eli Lilly joined earlier this year
The 20-year McCann veteran, who most recently headed McCann Health North America, has left the network for a dual role at inVentiv Health.
Chicago-based shop GA Communication Group says it's striving for the middle ground in an increasingly polarized agency landscape.
News on Rosetta, StoneArch and Intouch Solutions
We need for pharmaceutical companies to come forward and make the pledge to stop hiding data
California Democrat Henry Waxman, one of the strongest FDA overseers and drug industry critics on Capitol Hill, will step down when the House of Representatives ...
FDA's drug center says it has been so overwhelmed with industry's response to its new Breakthrough Therapy program that it is becoming difficult to promise ...
Now is the time for insurers to invest in differentiating their brand among younger and healthier people
Social media marketing has the best reach and results when it is part of a larger digital marketing strategy
Good stories feel as if they're meant for us, and they stay with us.
Ceci Zak, Chief operating officer, Diversified Agency Services, Omnicom
At Work With
Jack Hyndman, Creative, Fingerpaint
Promotions and hires for manufacturers, agencies and regulatory
It's time to make healthcare data Big, and for patients' sake, sexy
Skill Sets (advertising section)
A wave of more effective anti-cancer drugs has set the oncology world on fire with enthusiasm. While many hail this as a new era, an equally vocal faction questions the money spent for the value gained. This medical and commercial trend report for marketers of anti-cancer modalities touches on many of the latest shifts that have expedited product launches and otherwise impacted promotion and reimbursement of these drugs. Click here.
Pharma continues to struggle with its image. Exhibit A is the public debate around the price of, and access to, new and innovative meds. As countless transformative technologies hit market, has industry done enough to anchor its permission to innovate? To provide a closer look at trends affecting trust over the past year, MM&M presents this e-book, "The 2015 Edelman Trust Barometer." Click here.